TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

25.90$ +2.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Beam Therapeutics Inc (BEAM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,386 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BEAM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,291 1,460 1,360 1,261 1,171 1,104 1,467 1,391 1,311 1,481 1,481 1,386
1,040 1,211 1,122 1,029 946 878 1,248 1,175 1,099 1,269 1,267 1,179
169 436 288 293 230 282 528 282 268 295 288 220
1,015 1,190 1,095 1,008 926 851 1,220 1,150 1,075 1,245 1,212 1,153
512 478 446 407 380 370 344 344 345 243 316 319
220 206 187 177 166 182 142 174 183 97 75 81
12 13 12 13 13 13 13 13 13 14 15 15
3.2 1.6 2.8 4.4 3.8 3.9 7.7 11 9.5 10 12 13
100 100
779 981 913 854 791 734 1,123 1,047 966 1,238 1,164 1,067
-1,333 -1,190 -1,289 -1,380 -1,476 -1,567 -1,676 -1,778 -1,891 -1,641 -1,736 -1,858
79 83 82 82 82 83 88 102 103 105 103 104

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?